Evidence map›Paper›PMID 16149734›Full record

ArticleLipids2005

Stability of fatty acyl-coenzyme A thioester ligands of hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha.

Friedhelm Schroeder, Huan Huang, Heather A Hostetler, Anca D Petrescu, Rachel Hertz, Jacob Bar-Tana, Ann B Kier

Abstract read
PubMed Publisher
In one paragraph

Article in Lipids, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Liver fatty acid-binding protein and obesity.The Journal of nutritional biochemistry · 2010
    Review
  10. Hepatocyte nuclear factor 4alpha regulation of bile acid and drug metabolism.Expert opinion on drug metabolism & toxicology · 2009
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Friedhelm SchroederDepartment of Physiology and Pharmacology, Texas A&M University, TVMC, College Station, Texas 77843-4467, USA.
Huan Huang
Heather A Hostetler
Anca D Petrescu
Rachel Hertz
Jacob Bar-Tana
Ann B Kier
Texas A&M University · USHebrew University of Jerusalem · IL

Funding

FATTY ACID BINDING PROTEINS-LIGAND SPECIFICITYR01DK041402 · NIDDK · UNIVERSITY OF CINCINNATI · PI SCHROEDER, FRIEDHELM · 1989 to 2010
$4.4M
Fluorescent Probes:Multiplex Intracellular Imaging (RMI)P20GM072041 · NIGMS · TEXAS A&M UNIVERSITY SYSTEM · PI BURGESS, KEVIN · 2004 to 2008
$2.8M
Intracellular trafficking of long chain fatty acyl-CoAsF32DK066732 · NIDDK · TEXAS A&M UNIVERSITY SYSTEM · PI HOSTETLER, HEATHER A · 2004 to 2006
$142k
NIDDK NIH HHS DK066732NIDDK NIH HHS DK41402NIDDK NIH HHS F32 DK066732NIGMS NIH HHS P20 GM072041
6 · The paper itself

Abstract

Although long-chain fatty acyl-coenzyme A (LCFA-CoA) thioesters are specific high-affinity ligands for hepatocyte nuclear factor-4alpha (HNF-4alpha) and peroxisome proliferator-activated receptor-alpha (PPARalpha), X-ray crystals of the respective purified recombinant ligand-binding domains (LBD) do not contain LCFA-CoA, but instead exhibit bound LCFA or have lost all ligands during the purification process, respectively. As shown herein: (i) The acyl chain composition of LCFA bound to recombinant HNF-4alpha reflected that of the bacterial LCFA-CoA pool, rather than the bacterial LCFA pool. (ii) Bacteria used to produce the respective HNF-4alpha and PPARalpha contained nearly 100-fold less LCFA-CoA than LCFA. (iii) Under conditions used to crystallize LBD (at least 3 wk at room temperature in aqueous buffer), 16:1-CoA was very unstable in buffer alone. (iv) In the presence of the respective nuclear receptor (i.e., HNF-4alpha and PPARalpha), LBD 70-75% of 16:1-CoA was degraded after 1 d at room temperature in the crystallization buffer, whereas as much as 94-97% of 16:1-CoA was degraded by 3 wk. (v) Cytoplasmic LCFA-CoA binding proteins such as acyl-CoA binding protein, sterol carrier protein-2, and liver-FA binding protein slowed the process of 16:1-CoA degradation proportional to their respective affinities for this ligand. Taken together, these data for the first time indicated that the absence of LCFA-CoA in the crystallized HNF-4alpha and PPARalpha was due to the paucity of LCFA-CoA in bacteria as well as to the instability of LCFA-CoA in aqueous buffers and the conditions used for LBD crystallization. Furthermore, instead of protecting bound LCFA-CoA from autohydrolysis like several cytoplasmic LCFA-CoA binding proteins, these nuclear receptors facilitated LCFA-CoA degradation.

Indexed as

Acyl Coenzyme AAnimalsCarrier ProteinsCrystallizationDiazepam Binding InhibitorDrug StabilityEscherichia coliFatty Acid-Binding ProteinsHepatocyte Nuclear Factor 4LigandsMicePPAR alphaRabbitsRatsRecombinant ProteinsAcyl Coenzyme ACarrier ProteinsDiazepam Binding InhibitorFabp1 protein, mouseFatty Acid-Binding ProteinsHepatocyte Nuclear Factor 4LigandsPPAR alphaRecombinant Proteinssterol carrier proteins

Identifiers

PMID16149734
OpenAlexW2083721940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.